Clinical Trials Logo
  1. Home
  2. Atopic Dermatitis
  3. NCT04218877
  4. Details
NCT04218877 Clinical Trial

The Factors Affecting Atopic Dermatitis in Children Age 1-3

Atopic Dermatitis Clinical Trial

Official title:
Trigger's Influence on Atopic Dermatitis Manifestation in Children Under 3 Years Old

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT04218877
Other study ID # AkusherstvoPro
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 10, 2020
Est. completion date December 10, 2020

Study information
Verified date February 2022
Source Akusherstvo Pro
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study evaluates the influence of different triggers on atopic dermatitis manifestation in children under 3 years old.

Description:

In this study investigators evaluate the influence of atopic dermatitis triggers before labour, right after labour, in firsts weeks after labour, in first year. Investigators want to find the most popular and most important factors witch provoke atopic dermatitis manifestation and comparison the results with children without atopic dermatitis but with genetic predisposition to it.

Recruitment information / eligibility
Status Completed
Enrollment 300
Est. completion date December 10, 2020
Est. primary completion date December 10, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 1 Year to 3 Years
Eligibility Inclusion Criteria: - children 1-3 age without rash, without atopic dermatitis - children 1-3 age with recurrent atopic dermatitis Exclusion Criteria: - children 1-3 age with non-specific rush - children age 1-2 with atopic dermatitis without rush during previous year

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Russian Federation Amedclinic Moscow

Sponsors (1)
Lead Sponsor Collaborator
Akusherstvo Pro

Country where clinical trial is conducted

Russian Federation, 

Outcome
Type Measure Description Time frame Safety issue
Primary Trigger's factors for atopic dermatitis Vitamins during pregnancy; probiotics during pregnancy; school for future parents; vaginal birth; cesarian section; "golden hour" after delivery; antibiotics for mother and child right away after delivery; vaccination; breastfeeding; time after delivery for discharging hospital; using herbs for child's bathing; cosmetics for child; mother's diet after delivery; air's moisture; newborn's acne; pets; in what age child taste egg, cow's milk, fish, wheat, peanut, seafood; breastfeeding durations; infant formula in first year. All this factor will be aggregated as "yes" and "no" 3 years
See also
  Status Clinical Trial Phase
Completed NCT05018806 - Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis Phase 2
Terminated NCT03847389 - Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis Phase 1/Phase 2
Completed NCT04090229 - A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis Phase 1
Active, not recruiting NCT05388760 - Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1) Phase 2
Completed NCT05530707 - Evaluation of Acceptability, Skin Barrier Restoration and Balance of Atopic Skin Using Moisturizer N/A
Completed NCT02595073 - Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis Phase 3
Recruiting NCT05509023 - Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD) Phase 2
Recruiting NCT05048056 - Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis Phase 2
Completed NCT04598269 - Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis Phase 2
Recruiting NCT03936335 - An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
Withdrawn NCT03089476 - Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy N/A
Recruiting NCT05029895 - A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)
Terminated NCT03654755 - Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis Phase 2
Completed NCT04556461 - Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function Phase 2
Recruiting NCT04818138 - BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort N/A
Completed NCT03719742 - A Clinical Study to Evaluate the Safety and Efficacy of a Baby Cleanser and a Moisturizer N/A
Completed NCT05375955 - A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis. Phase 2
Completed NCT03441568 - In-home Use Test of the New Modified Diprobase Formulation to Assess the Safety and Tolerability in Infants and Children Under Physician's Control N/A
Recruiting NCT06366932 - Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models Phase 4
Completed NCT03304470 - A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis Phase 2